News for Revolution Medicines, Inc. (RVMD)

On May 14, 2025, HC Wainwright & Co., a reputable investment research firm, maintained its "Buy" rating for Revolution Medicines (RVMD). This decision was made

REDWOOD CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. ( RVMD), a late-stage clinical oncology company developing targeted therapie

U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Thursday. Shares of Groupon, Inc. GRPN rose sharply during Thursday's session a...

The following slide deck was published by Revolution Medicines, Inc.

Discover Revolution Medicines' Q1 2025 achievements in RAS(ON) cancer therapies, pivotal trials, and a robust roadmap.

Revolution Medicines, Inc. (NASDAQ:RVMD) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ETCompany ParticipantsRyan Asay - Senior Vice...

**media[618047]**

REDWOOD CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. ( RVMD), a late-stage clinical oncology company developing targeted therap

Revolution Medicines (RVMD) unveiled new clinical findings for their drug zoldonrasib, or RMC-9805, a specific RAS(ON) G12D inhibitor, administered solo in pati

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

**media[589978,589979]**

Health insurers rally after CMS increases payment to Medicare Advantage plans. Nvidia closes deal to acquire startup Lepton AI. China pledges to 'fight to the end' against new U.S. tariffs.

We recently compiled a list of the 10 Best Debt Free Mid Cap Stocks to Buy Now. In this article, we are going to take a look at where Revolution Medicines, Inc.

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Revolution Medicines, Inc.

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Revolution Medicines, Inc. (NASDAQ:RVMD) stands against the other best mid cap biotech stocks to buy. Is the Biotech Sector Oversaturated? On March 6, Jared Holz, Mizuho health care […]

We recently compiled a list of the 10 Cash-Rich Mid Cap Stocks To Buy Now. In this article, we are going to take a look at where Revolution Medicines, Inc.

Revolution Medicines Inc's innovative approach to targeting RAS and mTOR signaling pathways in precision oncology.Challenges of operating in a highly competiti

Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ETCompany ParticipantsRyan Asay - Senior Vice...

**media[552061]**